Repurposing triamterene as chloride intracellular channel 1 inhibitor via ligand-based approach for glioblastoma
Molecular Therapy
· Elsevier
Аннотация
Publication date: 7 October 2026 Source: Molecular Therapy, Volume 34, Issue 10 Author(s): Federica Barbieri, Francesca Cianci, Beatrice Federica Tremonti, Irene Dellacasagrande, Alessandro Corsaro, Guido Rey, Stefano Thellung, Noemi Barsotti, Valeria Marini, Manuela Stella, Giammarco Baiardi, Francesca Mattioli, Adriana Bajetto, Alessandra Pattarozzi, Pietro Amodeo, Michele Mazzanti, Rosa Maria Vitale, Tullio Florio
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Поиск и разработка лекарств»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Repurposing triamterene as chloride intracellular channel 1 inhibitor via ligand-based approach for glioblastoma. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626006039?dgcid=rss_sd_all
Repurposing triamterene as chloride intracellular channel 1 inhibitor via ligand-based approach for glioblastoma. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S1525001626006039?dgcid=rss_sd_all
“Repurposing triamterene as chloride intracellular channel 1 inhibitor via ligand-based approach for glioblastoma.” Molecular Therapy.
@article{article117399,
title = {Repurposing triamterene as chloride intracellular channel 1 inhibitor via ligand-based approach for glioblastoma},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626006039?dgcid=rss_sd_all}
}